GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Float Percentage Of Total Shares Outstanding

PCL (XKRX:241820) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 20, 2024)


View and export this data going back to 2017. Start your Free Trial

What is PCL Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PCL's float shares is 0.00 Mil. PCL's total shares outstanding is 54.04 Mil. PCL's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PCL's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PCL's Institutional Ownership is 0.02%.


PCL Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PCL's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/54.04
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PCL (XKRX:241820) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL (XKRX:241820) Headlines

No Headlines